Description of the SAGhE Cohort: A Large European Study of Mortality and Cancer Incidence Risks after Childhood Treatment with Recombinant Growth Hormone

BACKGROUND: The long-term safety of growth hormone treatment is uncertain. Raised risks of death and certain cancers have been reported inconsistently, based on limited data or short-term follow-up by pharmaceutical companies. Patients and Methods: The SAGhE (Safety and Appropriateness of Growth Hor...

Descripción completa

Detalles Bibliográficos
Autores principales: Swerdlow, Anthony J, Cooke, Rosi, Albertsson-Wikland, Kersti, Borgström, Birgi, Butler, Gar, Cianfarani, Stefan, Clayton, Pete, Coste, Joë, Deodati, Annalis, Ecosse, Emmanue, Gausche, Rut, Giacomozzi, Claudi, Kiess, Wielan, Hokken-Koelega, Anita C.S, Kuehni, Claudia E, Landier, Fabienn, Maes, Mar, Mullis, Primus-E, Pfaffle, Rolan, Sävendahl, Lar, Sommer, Gri, Thomas, Murie, Tollerfield, Sall, Zandwijken, Gladys R.J, Carel, Jean-Claud
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2015
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4611066/
https://www.ncbi.nlm.nih.gov/pubmed/26227295
http://dx.doi.org/10.1159/000435856

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4611066/
https://www.ncbi.nlm.nih.gov/pubmed/26227295
http://dx.doi.org/10.1159/000435856

Ejemplares similares